Singapore to Study Using More TCM Therapies in Public Healthcare
The health ministry has received 18 proposals on treatments that can be adopted and a committee will evaluate the scientific robustness of each of them, Health Minister Ong Ye Kung said Sunday. Some will be implemented in a 'controlled environment' in the city's public healthcare institutions for one to two years, he said, adding that the cost-effectiveness of each treatment will also be studied.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Associated Press
an hour ago
- Associated Press
ChiMei Medical Center adopts Inocras MRDVision and WGS bioinformatics platform for precision oncology in Taiwan
SAN DIEGO & TAINAN CITY, Taiwan--(BUSINESS WIRE)--Jul 7, 2025-- Inocras Inc., a global leader in whole-genome sequencing (WGS) and bioinformatics, today announced the signing of a Memorandum of Understanding (MOU) with ChiMei Medical Center (CMMC), a premier medical institution in Taiwan, and Trivator Biomedical Limited, a biomedical advisory firm in Taiwan. This expansion agreement aims to introduce Inocras's MRDVision tumor-informed minimal residual disease (MRD) test, utilizing circulating tumor DNA (ctDNA) blood samples, and CancerVision, its AI-powered bioinformatics cloud solution, to support WGS at CMMC, advancing Taiwan's precision oncology landscape. This initiative brings together CMMC's in-house WGS laboratory infrastructure with Inocras's advanced bioinformatics and ctDNA analysis platforms, creating a synergistic ecosystem for both research and clinical-grade genomics. The integration of MRDVision's ultra-sensitive ctDNA monitoring with CancerVision's scalable cloud analytics enables an end-to-end workflow—from sequencing to interpretation—within CMMC's existing clinical operations. CancerVision, Inocras's whole-genome tumor profiling test, forms the foundation for tumor-informed MRD analysis by first characterizing each patient's tumor genome. This enables the application of MRDVision, which monitors circulating tumor DNA (ctDNA) across the entire genome with a simulated limit of detection of 1 part per million (ppm), without requiring patient-specific panels. Powered by Ultima Genomics' ppmSeq technology and Inocras's bioinformatics platform, MRDVision identified tumor signals in 6% of cases missed by a leading MRD assay in a head-to-head clinical study of post-surgical ovarian and lung cancer patients. Integrated into CMMC's sequencing and clinical workflows, CancerVision and MRDVision together provide an end-to-end solution for genome-informed cancer monitoring and personalized treatment assessment. 'We are excited to partner with ChiMei Medical Center and Trivator to bring MRDVision and our CancerVision bioinformatics cloud solution to Taiwan,' said Jehee Suh, CEO of Inocras Inc. 'MRDVision's unmatched sensitivity, combined with CancerVision's robust cloud-based analytics, will empower CMMC to deliver cutting-edge cancer monitoring and precision medicine to patients.' Chi Mei Medical Center, renowned for its leadership in innovative healthcare, will leverage its clinical expertise and advanced infrastructure to implement the MRDVision and CancerVision platforms, further enhancing its whole-genome sequencing (WGS) capabilities. Trivator Biomedical Limited will provide local advisory and logistical support to ensure seamless integration into Taiwan's routine medical practice. 'We are proud to be a regional pioneer in integrating genomic technologies into routine oncology practice,' said Dr. Chein-Feng Li, Director of the Core Laboratory for Precision Medicine at Chi Mei Medical Center. 'By incorporating Inocras's MRDVision and CancerVision platforms, we are strengthening our capabilities in personalized cancer diagnostics and advancing Taiwan's leadership in translational genomic medicine.' 'This collaboration is a transformative step for precision medicine in Taiwan,' said Wen-Tsao Lee, founder of Trivator Biomedical Limited. 'By introducing MRDVision and CancerVision, we are combining Inocras's innovative technologies with CMMC's clinical excellence to redefine cancer care and genomic research.' The MOU serves as a framework for future definitive agreements to scope collaborative projects. The parties are committed to assessing market feasibility, engaging key opinion leaders, and establishing Taiwan as a hub for WGS-based precision medicine, with a focus on MRDVision and CancerVision. For more information about Inocras and its precision medicine solutions, visit View source version on CONTACT: Media Contact Inocras Inc. Gordon Cheung Email:[email protected] Phone: +852-3511-6347ChiMei Medical Center Chein Feng Li Email:[email protected] Phone: +886-6-281-2811 Ext 53680Trivator Biomedical Limited Wen-Tsao Lee Email:[email protected] Phone: +886-955-817-357 KEYWORD: NORTH AMERICA UNITED STATES SOUTH KOREA ASIA PACIFIC TAIWAN CALIFORNIA INDUSTRY KEYWORD: ONCOLOGY HEALTH HEALTH TECHNOLOGY GENETICS RESEARCH SCIENCE BIOTECHNOLOGY SOURCE: Inocras Inc. Copyright Business Wire 2025. PUB: 07/07/2025 10:31 AM/DISC: 07/07/2025 10:32 AM
Associated Press
an hour ago
- Associated Press
Rapid Line (RPDL) Launches BCI-Powered KIDWIN 3.0: Next-Gen Cognitive Learning Platform
SHENZHEN, CN / ACCESS Newswire / July 7, 2025 / Rapid Line Inc. (OTC:RPDL), a pioneering innovator in online education technology, today announced the global rollout of its groundbreaking 'Brain-Computer Interface (BCI) + Education' solution, marking a transformative upgrade of its flagship app KIDWIN into a 'Cognitive Navigation Learning Hub.' This breakthrough aims to revolutionize traditional education by leveraging real-time brain activity monitoring to deliver personalized learning experiences tailored to each child's unique cognitive needs. Solving Education's Biggest Challenges: Why Brains Need 'Smart Learning' Traditional education often struggles with three critical gaps: Rapid Line's BCI technology addresses these issues head-on. Through a child-friendly, non-invasive wearable device (in development), it captures real-time electroencephalogram (EEG) signals to monitor a child's focus levels, memory states, and cognitive load - providing scientific insights to optimize learning paths. KIDWIN 3.0: The 'Brain-Driven' Learning Revolution The upgraded KIDWIN platform introduces three revolutionary features designed to work in harmony with how the brain learns best: Why Rapid Line Leads the BCI Education Era Visionary Leadership: 'Unlocking Every Brain's Potential' Jiang Jian, CEO of Rapid Line Inc., stated: 'Education should not be a one-way infusion, but a natural release of the brain's potential. With BCI, we're moving beyond 'teaching to the test'-our goal is to empower every child to grow in the way that best suits their unique mind.' About Rapid Line Inc. Rapid Line Inc. is a development-stage company operating in the online education market segment. The company provides useful and effective type of online learning services, additional play-based studying in a form of quiz tool according to a school program available from anywhere using the phone and internet connection. Its online service provides a high quality, fundamental, comprehensive additional education through its mobile application 'KIDWIN' for Android and iOS mobile OS. Media Contact Email: [email protected] Phone: +86-15274931919 SOURCE: Rapid Line Inc press release
Yahoo
an hour ago
- Yahoo
'As if suffering could be graded': Initiative calls on full, immediate release of all hostages
Bo'u is "led by top professionals in the fields of physical and mental health in Israel, aimed at rescuing the hostages and preserving Israeli society," their website states. The Israel-based 'Bo'u' medical initiative (Come Together) penned a letter on Monday addressing top officials of the country's Health Ministry, asking them not to prioritize certain hostages to be released earlier than others and that they do not agree to only a partial release of the remaining 50 hostages, but a full and immediate release for all, according to a report by KAN, Israel's public broadcaster. Bo'u is "led by top professionals in the fields of physical and mental health in Israel, aimed at rescuing the hostages and preserving Israeli society," their website states. The initiative was created in response to the conditions of the hostages still held by Hamas in the Gaza Strip. It's known for hosting many lectures to raise public awareness on the matter, which are done through their speakers via Zoom. As of Monday, they have held over 700 lectures, according to the initiative. "Deciding on medical grounds who is 'worthy' of release and who will remain in captivity is not only professionally wrong but also intolerable from a conscientious point of view. It creates a reality of selection among hostages, as if suffering could be graded, entitlement to freedom measured, or the extent to which a person deserves to be rescued. "This type of medical selection is familiar to us from the darkest period in the history of the Jewish people," the association continued. "The very use of medical parameters to decide who will remain in captivity and who will be saved echoes historical memories that have no place in a sovereign and moral Jewish state." Israel's public broadcaster also quoted Dr. Einat Yehene, Head of Rehabilitation at the Hostage Families Forum's Health Division, who said that a partial release of hostages leads to jealousy in families whose loved ones still haven't been released and creates gaps between the families.
